| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2337 |
| Trial ID | NCT04318327 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PHE885 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma |
| Year | 2020 |
| Country | United States |
| Company sponsor | Novartis Pharmaceuticals |
| Other ID(s) | CADPT07A12101 |
| Cohort 1 | |||||||||
|
|||||||||